INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half…
First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half…